On ECHEMI
Home > Drugs > Adenosine Monophosphate for Injection

Adenosine Monophosphate for Injection

Function and Efficacy

This product is an anti-deoxyribonucleic acid (DNA) virus drug. Its pharmacological action is to bind to the viral deoxyribonucleic acid polymerase, reduce its activity and inhibit DNA synthesis. After entering the cell, adenosine monophosphate is phosphorylated to generate adenosine diphosphate (Ara-ADP) and adenosine triphosphate (Ara-ATP). The antiviral activity is mainly caused by adenosine triphosphate (Ara-ATP). Ara-ATP and deoxyadenosine triphosphate (dATP) compete to bind to viral DNAP, thereby inhibiting the activity of the enzyme and the synthesis of viral DNA. At the same time, it inhibits the activity of viral nucleotide reductase and inhibits the synthesis of viral DNA. It can also inhibit the activity of viral DNA terminal deoxynucleotidyl transferase, so that Ara-A penetrates into the viral DNA and connects to the end of the DNA chain 3prime;-OH position, inhibiting the continued synthesis of viral DNA.

Ingredients

Main ingredient: Adenosine monophosphate

Name Description Content CAS NO. Manufacturer
Vidarabine monophosphateIngredients

This product is an anti-deoxyribonucleic acid (DNA) virus drug. Its pharmacological action is to bind to the viral deoxyribonucleic acid polymerase, reduce its activity and inhibit DNA synthesis. After entering the cell, adenosine monophosphate is phosphorylated to generate adenosine diphosphate (Ara-ADP) and adenosine triphosphate (Ara-ATP). The antiviral activity is mainly caused by adenosine triphosphate (Ara-ATP). Ara-ATP and deoxyadenosine triphosphate (dATP) compete to bind to viral DNAP, thereby inhibiting the activity of the enzyme and the synthesis of viral DNA. At the same time, it inhibits the activity of viral nucleotide reductase and inhibits the synthesis of viral DNA. It can also inhibit the activity of viral DNA terminal deoxynucleotidyl transferase, so that Ara-A penetrates into the viral DNA and connects to the end of the DNA chain 3prime;-OH position, inhibiting the continued synthesis of viral DNA.

More
29984-33-6 12

Indication

Used to treat stomatitis, dermatitis, encephalitis and cytomegalovirus infection caused by herpes virus infection.

Usage and Dosage

Before use, add 2 ml of sterile saline to each bottle and dissolve it, then inject it intramuscularly or slowly intravenously, or follow the doctor's advice. For adults, take 5-10 mg/kg per day according to body weight. Pay close attention to the occurrence of adverse reactions during medication and deal with them in time.

Adverse Reactions

Pain at the injection site may be seen. In rare cases, neuromuscular pain and joint pain may occur, and thrombocytopenia, leukopenia or bone marrow giant cell hyperplasia may occasionally occur, which can recover on their own after discontinuation of the drug and are reversible. Symptomatic treatment can be used if necessary. The degree of adverse reactions is positively correlated with the dosage and course of treatment.

Drug Interactions

It should not be used with calcium-containing infusions. It should not be used with blood, plasma and protein infusions. Allopurinol can increase the toxicity of this product to the nervous system and it should not be used with allopurinol. Using it with interferon can aggravate adverse reactions.

Storage

Sealed, store in a cool and dry place

Packaging Specification

0.2g

Manufacturer

Datong Wuzhoutong Pharmaceutical Co., Ltd.

  • Founded in:

    2003-01-17
  • Address:

    No. 56, Xiantong Road, Development Zone, Datong City, Shanxi Province
  • Tax NO.:

    91140200748550344K
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.